论文部分内容阅读
目的:在对患者进行常规治疗基础上进行参附注射,观察患者的医疗效果情况。方法:急性心肌梗塞患者一共162例,采用随机抽取的方法将162例的患者分为两组。一组是治疗组,一组是对照组,治疗组82例,对照组80例。对162例患者同时进行治疗。对照组80例运用常规的治疗方法,治疗组80在常规处理方法基础上对患者的静脉输注参附注射液。结果:经过1周治疗之后,治疗组的康复率达到90%,而对照组仅有55%,从结果可见,治疗组效果远高于对照组。其中两组在经过1周治疗之后,LVEF、CO得到了明显的改善,但是治疗组的改善效果优于对照组。结论:参附注射液对于改善患者新功能有着显著的疗效,它可以通过清除患者体内氧自由基能力来保护患者心肌健康。
OBJECTIVE: To observe the medical effects of patients by taking Shenfu injection on the basis of routine treatment of patients. Methods: A total of 162 patients with acute myocardial infarction, a random sample of 162 patients were divided into two groups. One group is treatment group, one group is control group, 82 cases in treatment group and 80 cases in control group. 162 patients were treated simultaneously. 80 cases of the control group using conventional treatment methods, the treatment group 80 in the conventional treatment methods based on the patient’s intravenous infusion of Shenfu injection. Results: After a week of treatment, the recovery rate of the treatment group reached 90%, while the control group only 55%, the results show that the treatment group effect is much higher than the control group. After two weeks of treatment, the LVEF and CO in both groups were significantly improved, but the improvement in the treatment group was better than that in the control group. Conclusion: Shenfu injection has a significant effect on improving the new function of patients. It can protect the myocardial health of patients by removing the ability of oxygen free radicals in patients.